Your browser doesn't support javascript.
loading
Molecular Mechanism behind the Safe Immunostimulatory Effect of Withania somnifera.
Kalpana, Kriti; Yap, Shen; Tsuji, Moriya; Kawamura, Akira.
Afiliación
  • Kalpana K; Biochemistry Ph.D. Program, The Graduate Center of CUNY, New York, NY 10016, USA.
  • Yap S; Department of Chemistry, Hunter College of CUNY, New York, NY 10065, USA.
  • Tsuji M; Department of Chemistry, Hunter College of CUNY, New York, NY 10065, USA.
  • Kawamura A; Aaron Diamond AIDS Research Center, Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
Biomolecules ; 13(5)2023 05 12.
Article en En | MEDLINE | ID: mdl-37238698
Withania somnifera (L.) Dunal (family Solanaceae) is a medicinal plant known for, among many pharmacological properties, an immune boosting effect. Our recent study revealed that its key immunostimulatory factor is lipopolysaccharide of plant-associated bacteria. This is peculiar, because, although LPS can elicit protective immunity, it is an extremely potent pro-inflammatory toxin (endotoxin). However, W. somnifera is not associated with such toxicity. In fact, despite the presence of LPS, it does not trigger massive inflammatory responses in macrophages. To gain insights into the safe immunostimulatory effect of W. somnifera, we conducted a mechanistic study on its major phytochemical constituent, withaferin A, which is known for anti-inflammatory activity. Endotoxin-triggered immunological responses in the presence and absence of withaferin A were characterized by both in vitro macrophage-based assay and in vivo cytokine profiling in mice. Collectively, our results demonstrate that withaferin A selectively attenuates the pro-inflammatory signaling triggered by endotoxin without impairing other immunological pathways. This finding provides a new conceptual framework to understand the safe immune-boosting effect of W. somnifera and possibly other medicinal plants. Furthermore, the finding opens a new opportunity to facilitate the development of safe immunotherapeutic agents, such as vaccine adjuvants.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plantas Medicinales / Withania Límite: Animals Idioma: En Revista: Biomolecules Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plantas Medicinales / Withania Límite: Animals Idioma: En Revista: Biomolecules Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos